New arthritis drug takes first step in human testing
NCT ID NCT05576012
Summary
This was the first study in humans to test a new drug called SOL-116 for rheumatoid arthritis. Researchers gave single doses to 56 healthy volunteers and arthritis patients to check if it was safe and how the body processes it. The main goal was to understand side effects and determine safe dosage levels before larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHDR (Stichting Centre for Human Drug Research)
Leiden, Netherlands
-
QPS Netherlands B.V.
Groningen, Netherlands
Conditions
Explore the condition pages connected to this study.